{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:10:48Z","timestamp":1761718248448,"version":"build-2065373602"},"reference-count":83,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are poorly understood autoimmune liver diseases. Immunosuppression is used to treat AIH and ursodeoxycholic acid is used to slow the progression of PBC. Nevertheless, a proportion of patients with both disorders progress to liver failure. Following liver transplantation, up to a third of patients with PBC experience recurrent disease. Moreover a syndrome referred to as \u201cde novo AIH\u201d occurs in a proportion of patients regardless of maintenance immunosuppression, who have been transplanted for disorders unrelated to AIH. Of note, the use of cyclosporine A appears to protect against the development of recurrent PBC and de novo AIH even though it is a less potent immunosuppressive compared to tacrolimus. The reason why cyclosporine A is protective has not been determined. However, a virus resembling mouse mammary tumor virus (MMTV) has been characterized in patients with PBC and AIH. Accordingly, we hypothesized that the protective effect of cyclosporine A in liver transplant recipients may be mediated by the antiviral activity of this cyclophilin inhibitor. Treatment of the MMTV producing MM5MT cells with different antivirals and immunosuppressive agents showed that both cyclosporine A and the analogue NIM811 inhibited MMTV production from the producer cells. Herein, we discuss the evidence supporting the role of MMTV-like human betaretrovirus in the development of PBC and  de novo AIH and speculate on the possibility that the agent may be associated with disease following transplantation. We also review the mechanisms of how both cyclosporine A and NIM811 may inhibit betaretrovirus production in vitro.<\/jats:p>","DOI":"10.3390\/v5020423","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T11:29:13Z","timestamp":1359026953000},"page":"423-438","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is there a Role for Cyclophilin Inhibitors in the Management of Primary Biliary Cirrhosis?"],"prefix":"10.3390","volume":"5","author":[{"given":"Shawn","family":"Wasilenko","sequence":"first","affiliation":[{"name":"Department of Medicine, Zeidler Ledcor Centre, University of Alberta Hospital, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Montano-Loza","sequence":"additional","affiliation":[{"name":"Department of Medicine, Zeidler Ledcor Centre, University of Alberta Hospital, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mason","sequence":"additional","affiliation":[{"name":"Department of Medicine, Zeidler Ledcor Centre, University of Alberta Hospital, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: A 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC study group","volume":"324","author":"Poupon","year":"1991","journal-title":"N. Eng. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(02)00103-9","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"2","author":"Neuberger","year":"2003","journal-title":"Autoimmun Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1089-3261(05)70167-7","article-title":"Autoimmune liver disease. Current standards, future directions","volume":"5","author":"Gish","year":"2001","journal-title":"Clin. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cld.2008.02.006","article-title":"Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis","volume":"12","author":"Mason","year":"2008","journal-title":"Clin. Liver. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(93)90422-9","article-title":"Cyclosporin A treatment in primary biliary cirrhosis: Results of a long-term placebo controlled trial","volume":"104","author":"Lombard","year":"1993","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.510240342","article-title":"Hepatitis and cholestasis in a middle-aged woman","volume":"24","author":"Perrillo","year":"1996","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/jlts.2003.50096","article-title":"Recurrent primary biliary cirrhosis","volume":"9","author":"Neuberger","year":"2003","journal-title":"Liver. Transpl."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"306","author":"Neuberger","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver. Transpl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: Peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver. Transpl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Wasilenko","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver. Transpl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"McMaster","year":"2001","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver. Transpl."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"ref_19","first-page":"871","article-title":"Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis","volume":"30","author":"Wasilenko","year":"2010","journal-title":"Liver. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2012.02832.x","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation","volume":"32","author":"Ma","year":"2012","journal-title":"Liver. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am. J. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.dld.2010.05.019","article-title":"Current topics in autoimmune hepatitis","volume":"42","author":"Muratori","year":"2010","journal-title":"Dig. Liver. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.transproceed.2006.03.071","article-title":"De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis","volume":"38","author":"Aguilera","year":"2006","journal-title":"Transplant. Proc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1399-3046.2005.00470.x","article-title":"Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation","volume":"10","author":"Gibelli","year":"2006","journal-title":"Pediatr. Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00007890-200107270-00018","article-title":"Posttransplant immune hepatitis in pediatric liver transplant recipients: Incidence and maintenance therapy with azathioprine","volume":"72","author":"Andries","year":"2001","journal-title":"Transplantation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: A rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00007890-200201150-00015","article-title":"Late cellular rejection in paediatric liver transplantation: aetiology and outcome","volume":"73","author":"Dhawan","year":"2002","journal-title":"Transplantation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/lt.20673","article-title":"Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience","volume":"12","author":"Riva","year":"2006","journal-title":"Liver. Transpl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.20404","article-title":"Antibodies against cytokeratin 8\/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation","volume":"11","author":"Inui","year":"2005","journal-title":"Liver. Transpl."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.transproceed.2008.05.042","article-title":"De novo autoimmune hepatitis following liver transplantation: a case report","volume":"40","author":"Barletta","year":"2008","journal-title":"Transplant. Proc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary Biliary Cirrhosis in Monozygotic and Dizygotic Twins: Genetics, Epigenetics, and Environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2005-916319","article-title":"Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology","volume":"25","author":"Selmi","year":"2005","journal-title":"Semin. Liver. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.48.3.397","article-title":"HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility","volume":"48","author":"Donaldson","year":"2001","journal-title":"Gut"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hirschfield, G., Chapman, R., Karlsen, T., Lammert, F., Lazaridis, K., and Mason, A. The Genetics of Complex Cholestatic Disorders. in Submission 2012.","DOI":"10.1053\/j.gastro.2013.03.053"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ng.631","article-title":"Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis","volume":"42","author":"Hirschfield","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/gene.2011.89","article-title":"Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes","volume":"13","author":"Hirschfield","year":"2012","journal-title":"Genes and Immunity"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0016-5085(91)90090-8","article-title":"HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis","volume":"101","author":"Manns","year":"1991","journal-title":"Gastroenterology"},{"key":"ref_43","unstructured":"Sherlock, S. (1993). Primary Biliary Cirrhosis: Definition and Epidemiological Features, Kluwer Academic Publishers."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/bmj.281.6243.772","article-title":"Primary biliary cirrhosis: an epidemiological study","volume":"281","author":"Trigger","year":"1980","journal-title":"Br. Med. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clin. Liver. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2007-1007179","article-title":"The geoepidemiology of primary biliary cirrhosis","volume":"17","author":"Metcalf","year":"1997","journal-title":"Semin. Liver. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(97)05419-6","article-title":"Primary Biliary Cirrhosis","volume":"350","author":"Neuberger","year":"1997","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.gcb.2010.04.014","article-title":"Linking human betaretrovirus infection with primary biliary cirrhosis","volume":"34","author":"Mason","year":"2010","journal-title":"Gastroenterol Clin. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.20024","article-title":"Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis","volume":"39","author":"Xu","year":"2004","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1073\/pnas.1433063100","article-title":"Does a betaretrovirus infection trigger primary biliary cirrhosis?","volume":"100","author":"Xu","year":"2003","journal-title":"Proc. Natl. Acad. Sci.U.S.A."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2004.05.033","article-title":"Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2011.01.037","article-title":"Mouse Mammary Tumor Virus in Anti-Mitochondrial Antibody Producing Mouse Models","volume":"55","author":"Zhang","year":"2011","journal-title":"J. Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/j.1572-0241.2004.40741.x","article-title":"Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis","volume":"99","author":"Mason","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1365-2036.2008.03799.x","article-title":"Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol","volume":"28","author":"Mason","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2036.2007.03402.x","article-title":"Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders","volume":"26","author":"McDermid","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e1000524","DOI":"10.1371\/journal.ppat.1000524","article-title":"Target cell cyclophilins facilitate human papillomavirus type 16 infection","volume":"5","author":"Patel","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.1128\/JVI.00980-12","article-title":"Cyclophilins Facilitate Dissociation of the Human Papillomavirus Type 16 Capsid Protein L1 from the L2\/DNA Complex following Virus Entry","volume":"86","author":"Williams","year":"2012","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1128\/JVI.02168-09","article-title":"CD147\/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells","volume":"84","author":"Watanabe","year":"2010","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1073\/pnas.111583198","article-title":"CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A","volume":"98","author":"Pushkarsky","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/JVI.79.1.176-183.2005","article-title":"Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells","volume":"79","author":"Hatziioannou","year":"2005","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"12800","DOI":"10.1128\/JVI.78.23.12800-12808.2004","article-title":"Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity","volume":"78","author":"Sokolskaja","year":"2004","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1128\/jvi.70.7.4220-4227.1996","article-title":"Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses","volume":"70","author":"Braaten","year":"1996","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1128\/jvi.64.8.4037-4041.1990","article-title":"Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner","volume":"64","author":"Schmidt","year":"1990","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/JVI.02614-07","article-title":"Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro","volume":"82","author":"Yang","year":"2008","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e1001118","DOI":"10.1371\/journal.ppat.1001118","article-title":"A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach","volume":"6","author":"Yang","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bcp.2008.12.019","article-title":"Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase","volume":"77","author":"Heck","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e9815","DOI":"10.1371\/journal.pone.0009815","article-title":"Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A","volume":"5","author":"Fernandes","year":"2010","journal-title":"PLoS One"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1128\/JVI.00393-11","article-title":"Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner","volume":"85","author":"Foster","year":"2011","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/AAC.01236-09","article-title":"Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors","volume":"54","author":"Puyang","year":"2010","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.00189-09","article-title":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein","volume":"53","author":"Qing","year":"2009","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1099\/vir.0.034983-0","article-title":"Cyclosporin A inhibits the replication of diverse coronaviruses","volume":"92","author":"Thiel","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1073\/pnas.92.11.4977","article-title":"Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: A possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression","volume":"92","author":"Renoir","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0008-8749(85)90046-2","article-title":"In vivo effects of cyclosporine on influenza A virus-infected mice","volume":"91","author":"Schiltknecht","year":"1985","journal-title":"Cell Immunol."},{"key":"ref_75","first-page":"63","article-title":"The hepatitis C virus NS2\/3 protease","volume":"9","author":"Welbourn","year":"2007","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e37277","DOI":"10.1371\/journal.pone.0037277","article-title":"Cyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathways","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e1000546","DOI":"10.1371\/journal.ppat.1000546","article-title":"Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics","volume":"5","author":"Kaul","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/hep.23281","article-title":"Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A","volume":"50","author":"Ciesek","year":"2009","journal-title":"Hepatology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"43202","DOI":"10.1074\/jbc.M305414200","article-title":"Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression","volume":"278","author":"Zander","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/372359a0","article-title":"Specific incorporation of cyclophilin A into HIV-1 virions","volume":"372","author":"Franke","year":"1994","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/372363a0","article-title":"Functional association of cyclophilin A with HIV-1 virions","volume":"372","author":"Thali","year":"1994","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(10)61343-8","article-title":"Killing two birds with one stone","volume":"377","author":"Schembri","year":"2011","journal-title":"Lancet"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/5\/2\/423\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:44:31Z","timestamp":1760219071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/5\/2\/423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2]]}},"alternative-id":["v5020423"],"URL":"https:\/\/doi.org\/10.3390\/v5020423","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}